Rigel Pharmaceuticals Inc (RIGL) stock
RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$42.92−0.81 (-1.85%)
Close on Nov 17, 2026Market cap $801.74MP/E 2.7Yield –
Rigel Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Rigel Pharmaceuticals's market cap was $875.21M on Nov 11, 2026, against $926.97M a year earlier. Over the last 5 years it ranged from $112.39M to $1.01B, with a median of $301.12M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $875.21M | +11.3% |
| 2025 | Dec 31, 2025 | $786.34M | +166.6% |
| 2024 | Dec 31, 2024 | $295.00M | +18.5% |
| 2023 | Dec 29, 2023 | $248.92M | -0.8% |
| 2022 | Dec 30, 2022 | $251.01M | -44.8% |
| 2021 | Dec 31, 2021 | $454.60M | -23.0% |
| 2020 | Dec 31, 2020 | $590.27M | +64.8% |
| 2019 | Dec 31, 2019 | $358.23M | +23.3% |
| 2018 | Dec 31, 2018 | $290.55M | -20.7% |
| 2017 | Dec 29, 2017 | $366.22M | +74.0% |
| 2016 | Dec 30, 2016 | $210.47M | -20.8% |
| 2015 | Dec 31, 2015 | $265.62M | +34.1% |
| 2014 | Dec 31, 2014 | $198.14M | -7.3% |
| 2013 | Dec 31, 2013 | $213.66M | -54.2% |
| 2012 | Dec 31, 2012 | $466.44M | -17.0% |
| 2011 | Dec 30, 2011 | $562.03M | +82.6% |
| 2010 | Dec 31, 2010 | $307.80M | – |
See a number that looks wrong?